Your current location:Home > Management team
Management team
    Zhang Lin,Vice president of investment and financing

    Vice president of investment and financing 

    Having rich experiences in investment and financing over a decade 

    The expert in investment and financing field

    Yuexia Ma,Director of medical department, MD, and associate chief physician

    Director of medical department, MD, and associate chief physician, overseas returnee of post-doctoral from England. Having accomplished nearly 1500 protocol design and CSR, Since from the year 2003 to 2021.

    Wang Yanni, director of data management department wokrplace:Beijing

    Wang Yanni, who has a medical qualification certificate, has worked in Quanhui medical equipment, Mercedes pharmaceuticals, and Hongde medical clinical research Co., Ltd.

    Since 2010, it has been working as a data management department. She has led all aspects of data management in international multi center clinical trial projects. She has worked with data management teams such as the United States to optimize workflow and develop and improve data management standards.

    Familiar with all aspects of clinical data items, including data entry, verification, and project meetings. The division of labor, process, quality and coordination with other personnel in the project will support all aspects of data management in the project, including CRF auditing, data verification planning, data entry, verification, external data consistency checking, and database locking.


    Hui Yu,Director of registration and regulatory department

    Director of registration and regulatory department,master’s degree in pharmacology

    Dedicated to the registration services of Domestic and imported drugs 

    Lifeng Jin,Senior director of biological statistics and SAS programming department, master’s degree in medical statistics

    Senior director of biological statistics and SAS programming department, master’s degree in medical statistics

    Nine-year experiences as the statistician, over 200+ project experiences, good at new drug design and statistics.

    Participated in SAP and statistical report of many FDA application projects; accomplished 200+ clinical trial. Having purchased an internationally advanced, FDA compliant, SAS based cloud TFL automatic generation system from the United States.

    Jinfang li,Director of project management department

    Director of project management department, master’s degree in clinical pharmacy. Worked as a PM in Livzon Pharmaceutical Group Inc and other companies for more than 10 years. 

    As to today, H&J PM’s team had expanded and reaches to 10+ project managers. 


    Wenshan Jin,Director of TMF quality assurance, Master’s degree

    Director of TMF quality assurance, Master’s degree, 30+ years clinical experiences, 100+ project audit experiences, Former quality assurance department director in Tigermed. 

    Bing Ren,F&S general manager, master’s degree in clinical

    P&S general manager, master’s degree in clinical

    Zhao Hui,Senior director of quality assurance and training department

    Senior director of quality assurance and training department, master’s degree in pharmacology.  Five years GCP training management experiences, Responsible to make company training plan and SOP management


    Huo Hongjian, Master of Management Research and Development Center, Beijing

    After graduating from Beijing University of Chemical Technology in 2000, he has been engaged in information system development for 6 years. In 2009, he received a master's degree in Business Administration from Chinese Academy of Sciences and engaged in financial data analysis for 5 years. It mainly involves information system development, data management, data analysis, model development (asset risk, retail model) and team building.

    He has successively served as project manager of Tianzheng R&D Department of Peking University, R&D manager of Xu Ji Electric (Beijing), project manager of Computer Center of National Audit Administration, and director of data and Information Department of Dongfang Asset Management Company. 

    In 2012, he joined Humboleqiang and was responsible for the work of the Department of Statistics, the Department of Statistical Procedure and the Innovation Center. He chaired and participated in the statistical analysis of a number of early clinical trials and domestic clinical trials in the United States, including: more than 20 clinical research and development projects of new drugs in the United States, 2 new drugs in China, 5 phase IV projects, and more than 20 instruments in the field of cancer, CNS, endocrine, and painstaking efforts. Tubes, analgesics, instruments, of which tumors are the most common.

    In terms of innovative research and development, more than a dozen software copyrights and patents have been applied, and many automation systems have been developed, which have been applied to practical clinical projects. The automation systems include: automatic random reporting system, laboratory data automatic input system, automated graphics system, automatic data verification system, Patient Profiles system, BE-PK automatic analysis system, automated reporting system. Unification.